Document:

Exhibit 4.5

 

Execution version

 

AMENDED AND RESTATED

COMMON STOCK PURCHASE WARRANT

 

TELLURIAN
INC. 

 

	Warrant Shares: 9,000,000 	Issue
Date: April 29, 2020

 

THIS AMENDED AND RESTATED
COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, Nineteen77 Capital Solutions
A LP or its permitted assigns (the “Holder”) is entitled, upon the terms and subject to the conditions set forth
herein, in the amounts hereinafter specified from time to time on or after the Issue Date and on or prior to March 23, 2025 (the
“Termination Date”), to purchase from Tellurian Inc., a Delaware corporation (the “Company”),
up to 9,000,000 shares (as adjusted from time to time pursuant to the terms of this Warrant, the “Warrant Shares”)
of the Company’s common stock, par value $0.01 per share (“Common Stock”), at a purchase price of $1.00
per share (such purchase price, as adjusted from time to time pursuant to the terms of this Warrant, the “Exercise Price”).
The Company and the Holder each acknowledges and agrees that this Warrant amends and restates in its entirety and replaces that
certain Amended and Restated Common Stock Purchase Warrant that was issued by the Company to the Holder on March 23, 2020 (the
“Original Issue Date”), which is deemed cancelled as of the date hereof.

 

Section 1.
 Definitions. As used in this Warrant, the terms set forth in this Section 1 shall have the respective meanings assigned
to them in this Section 1.

 

“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, is in control
of, is controlled by, or is under common control with, such Person. For purposes of this definition, “control” of a
Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of such Person, whether through the exercise of voting power, by contract or otherwise.

 

“Aggregate
Exercise Price” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant
is then being exercised pursuant to Section 2 hereof, multiplied by (b) the Exercise Price in effect
as of the applicable Exercise Date in accordance with the terms of this Warrant.

 

“Attribution
Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder
funds or managed accounts, currently, or from time to time after the Issue Date, directly or indirectly managed or advised by the
Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder
or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any
of the foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated
with the Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose
of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.

 

    1

     

    

 

“Bloomberg”
means Bloomberg Financial Markets

 

“Business
Day” means any day except any Saturday, any Sunday or any day on which banking institutions in the State of New York
are authorized or required by law or other governmental action to close.

 

“Commission”
means the Securities and Exchange Commission.

 

“Credit and
Guaranty Agreement” means that certain Credit and Guaranty Agreement dated as of May 23, 2019, by and among Driftwood
Holdings LP (converted from Driftwood Holdings LLC), as borrower, the guarantors party thereto, the lenders from time to time party
thereto, and Wilmington Trust, N.A. as administrative agent and collateral agent for the lenders, as amended, restated, supplemented
or otherwise modified from time to time.

 

“Daily VWAP”
means, for any VWAP Trading Day, the per share volume-weighted average price of the Common Stock as displayed under the heading
“Bloomberg VWAP” on Bloomberg page “TELL <EQUITY> VAP” (or, if such page is not available, its equivalent
successor page) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary
trading session on such VWAP Trading Day (or, if such volume-weighted average price is unavailable, the market value of one share
of Common Stock on such VWAP Trading Day, determined, using a volume-weighted average price method, by a nationally recognized
independent investment banking firm selected by the Company). The Daily VWAP will be determined without regard to after-hours trading
or any other trading outside of the regular trading session

 

“Event of
Default” has the meaning set forth in the Credit and Guaranty Agreement.

 

“Exercise
Date” means the date on which a duly completed and executed Notice of Exercise has been delivered to the Company in accordance
with Section 2(a) of this Warrant.

 

“Permitted
Fund Transferees” means any fund or funds managed, directly or indirectly, by UBS O’Connor LLC, which funds are
managed by the same key persons that exercise managerial control and authority of Nineteen77 Capital Solutions A LP as of the Issue
Date.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Third Amendment
to Credit and Guaranty Agreement” means that certain Third Amendment to Credit and Guaranty Agreement, dated as of April
28, 2020, by and among Driftwood Holdings LP (converted from Driftwood Holdings LLC), as borrower, the guarantors party thereto,
the lenders from time to time party thereto, and Wilmington Trust, N.A. as administrative agent and collateral agent for the lenders.

 

“Trading Day”
means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

 

    2

     

    

 

“VWAP Market
Disruption Event” means, with respect to any date, (A) the failure by the principal U.S. national or regional securities
exchange on which the Common Stock is then listed, or, if the Common Stock is not then listed on a U.S. national or regional securities
exchange, the principal other market on which the Common Stock is then traded, to open for trading during its regular trading session
on such date; or (B) the occurrence or existence, for more than one half hour period in the aggregate, of any suspension or limitation
imposed on trading (by reason of movements in price exceeding limits permitted by the relevant exchange or otherwise) in the Common
Stock or in any options contracts or futures contracts relating to the Common Stock, and such suspension or limitation occurs or
exists at any time before 1:00 p.m., New York City time, on such date.

 

“VWAP Trading
Day” means a day on which (A) there is no VWAP Market Disruption Event; provided that the Holder, by notice to the Company,
may waive any such VWAP Market Disruption Event; and (B) trading in the Common Stock generally occurs on the principal U.S. national
or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national
or regional securities exchange, on the principal other market on which the Common Stock is then traded. If the Common Stock is
not so listed or traded, then “VWAP Trading Day” means a Business Day.

 

“Weighted
Average Price” means, for any security as of any date, the dollar volume-weighted average price for such security on
the Trading Market during the period beginning at 9:30:01 a.m., New York time (or such other time as the Trading Market publicly
announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market
publicly announces is the official close of trading), as reported by Bloomberg through its “Volume at Price” function
or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on
the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time (or such other time
as such market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time
as such market publicly announces is the official close of trading), as reported by Bloomberg, or, if no dollar volume-weighted
average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest
closing ask price of any of the market makers for such security as reported in the OTC Link or “pink sheets” by OTC
Markets Group Inc. (formerly Pink OTC Markets Inc.). If the Weighted Average Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as
mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination, reclassification or other similar transaction during the applicable calculation period

 

Section 2. Exercise.

 

a)                 
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part
in increments of 25,000 Warrant Shares, subject to the following limitations:

 

    3

     

    

 

i.           
Immediately upon the Issue Date, the aggregate amount of Warrant Shares in respect of which the purchase rights represented
by this Warrant may be exercised shall be 3,000,000 (the “First Tranche”) (as adjusted from time to time pursuant
to the terms of this Warrant and subject to Section 2(a)(v)). The period between the Issue Date and prior to the date that is six
months after the Original Issue Date is an “Exercise Period.”

 

ii.           
Upon the date that is six months after the Original Issue Date, the aggregate amount of Warrant Shares in respect of which
the purchase rights represented by this Warrant may be exercised shall be increased by 2,000,000 (the “Second Tranche”)
(as adjusted from time to time pursuant to the terms of this Warrant and subject to Section 2(a)(v)). The period between the date
that is six months after the Original Issue Date and prior to the date that is 12 months after the Original Issue Date is an “Exercise
Period.”

 

iii.           
Upon the date that is 12 months after the Issue Date, the aggregate amount of Warrant Shares in respect of which the purchase
rights represented by this Warrant may be exercised shall be increased by 2,000,000 (the “Third Tranche”) (as
adjusted from time to time pursuant to the terms of this Warrant and subject to Section 2(a)(v)). The period between the date that
is 12 months after the Original Issue Date and prior to the date that is 15 months after the Original Issue Date is an “Exercise
Period.”

 

iv.           
Upon the date that is 15 months after the Original Issue Date, the aggregate amount of Warrant Shares in respect of which
the purchase rights represented by this Warrant may be exercised shall be increased by 2,000,000 (the “Fourth Tranche”
and together with the First Tranche, Second Tranche and Third Tranche, each a “Tranche”) (as adjusted from time
to time pursuant to the terms of this Warrant and subject to Section 2(a)(v)). The period between the date that is 15 months after
the Original Issue Date and prior to the Termination Date is an “Exercise Period.”

 

v.            Notwithstanding
anything to the contrary herein, in the event any portion of the outstanding principal amount of the Loans (as defined in the
Credit and Guaranty Agreement) is repaid in cash during an Exercise Period (including any such repayment on the Issue Date,
but excluding for the avoidance of doubt the conversion of Loans to Common Shares pursuant to Section 2(c) of the Third
Amendment to Credit and Guaranty Agreement), the number of Warrant Shares represented by each Tranche of each subsequent
Exercise Period shall be equal to (A) the number of Warrant Shares represented by such Tranche (as adjusted from time to time
pursuant to the terms of this Warrant), multiplied by (B) a fraction (x) the numerator of which is (I) $55,000,000; minus (II)
as of the most recent Monthly Payment Date (as defined in the Credit and Guaranty Agreement), the principal amount of the
Loans (as defined in the Credit and Guaranty Agreement) that have been repaid in cash after the Issue Date, and (y) the
denominator of which is $55,000,000. Further, in the event that the outstanding balance of the Loans is repaid in full during
an Exercise Period, then each Tranche with respect to all subsequent Exercise Periods shall represent zero Warrant
Shares.

 

    4

     

    

 

Subject to
the foregoing limitations, exercise of the purchase rights represented by this Warrant may be made, by delivery to the Company
of a duly completed and executed facsimile copy or PDF copy submitted by facsimile or e-mail attachment of the Notice of Exercise
in the form attached hereto (“Notice of Exercise”). Within two (2) Trading Days following delivery of the Notice
of Exercise, the Holder shall deliver the Aggregate Exercise Price to the Company, by wire transfer of immediately available funds
to an account designated by the Company in writing or cashier’s check drawn on a United States bank, unless the utilization
of the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Exercise be required. Notwithstanding anything in this Warrant to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available under this Warrant and
this Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
at the same time that the final Notice of Exercise is delivered to the Company.

 

b)                 
Partial Exercise. Any partial exercise of this Warrant resulting in the purchase of a portion of the total number
of Warrant Shares then available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder by an amount equal to the applicable number of Warrant Shares purchased as a result of such partial exercise. The Company
shall maintain records reflecting the number of Warrant Shares purchased pursuant to the exercise of this Warrant and the date(s)
of such purchase(s).

 

c)                 
Cashless Exercise. This Warrant may be exercised, in whole or in part in increments of 25,000 Warrant Shares (and
subject to the limitations on exercise set forth in Sections 2(a)(i)-(v)), at any time or times on or after the Issue Date and
on or prior to the Termination Date at the election of the Holder (in the Holder’s sole discretion) by means of a “cashless
exercise,” pursuant to which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained
by dividing ((A-B) * (X)) by (A), where:

 

(A) = as
applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such
Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or
(2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular
trading hours” (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such
Trading Day, or (ii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a
Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof during such Trading
Day or after the close of “regular trading hours” on such Trading Day;

 

    5

     

    

 

	 	(B) = 	the Exercise Price of this Warrant; and

 

	 	(X) =	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
if such exercise were by means of a cash exercise rather than a cashless exercise.

 

Any cashless
exercise of this Warrant shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder by an
amount equal to the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms
of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise and not the number of Warrant
Shares actually received by the Holder.

 

For
purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that any Warrant Shares
issued in a cashless exercise pursuant to this Section 2(c) shall be deemed to have been acquired by the Holder, and the holding
period for such Warrant Shares shall be deemed to have commenced, on the Issue Date.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date on the Trading Market
on which the Common Stock is then listed or quoted as reported by Bloomberg L.P., (b)  if the Common Stock is not then listed
or quoted for trading on a Trading Market and if prices for the Common Stock are then reported in the “Pink Sheets”
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the
most recent bid price per share of the Common Stock so reported, or (c) in all other cases, the fair market value of a share
of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding
anything in this Warrant to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise
pursuant to this Section 2(c) without any action on the part of the Holder.

 

 d)                  Mechanics of Exercise.

 

i.                     Delivery
of Warrant Shares Upon Exercise. The Company shall deliver, or shall cause to be delivered, the Warrant Shares acquired
hereunder to the Holder within one (1) Trading Day after the date on which the Aggregate Exercise Price has been delivered
pursuant to Section 2(a) (such date, the “Warrant Share Delivery Date”). Such Warrant Shares shall be in
certificated form and bear an appropriate restrictive legend unless otherwise required under the terms of this Warrant. The
person in whose name any Warrant Shares are to be issued upon exercise of this Warrant shall be deemed to have become the
holder of record of such shares on the date on which this Warrant was validly exercised, irrespective of the actual date of
issuance of such Warrant Shares, except that, if the date of such valid exercise is a date when the stock transfer books of
the Company are closed, such person shall be deemed to have become the holder of such Warrant Shares at the close of business
on the next succeeding date on which the stock transfer books are open.

 

ii.                    
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at
the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver
to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant.

 

    6

     

    

 

iii.                 
Company’s Failure to Timely Deliver Warrant Shares. If either (I) the Company shall fail for any reason or
for no reason on or prior to the applicable Warrant Share Delivery Date, if (x) the Company’s transfer agent is not participating
in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program (“FAST”),
to issue to the Holder a certificate for the number of shares of Common Stock to which the Holder is entitled and register such
Common Stock on the Company’s share register or (y) the Company’s transfer agent is participating in FAST, to credit
the Holder’s balance account with DTC such number of shares of Common Stock to which the Holder is entitled upon the Holder’s
exercise of this Warrant or (II) a registration statement covering the issuance or resale of the Warrant Shares that are the subject
of the Notice of Exercise (the “Exercise Notice Warrant Shares”) is not available for the issuance or resale,
as applicable, of such Exercise Notice Warrant Shares and (x) the Company fails to promptly, but in no event later than two (2)
Business Days after such registration statement becomes unavailable, to so notify the Holder and (y) the Company is unable to
deliver the Exercise Notice Warrant Shares electronically without any restrictive legend by crediting such aggregate number of
Exercise Notice Warrant Shares to the Holder’s or its designee’s balance account with DTC through its Deposit / Withdrawal
At Custodian system (the event described in the immediately foregoing clause (II) is hereinafter referred as a “Notice
Failure” (provided that no Notice Failure shall be deemed to have occurred if the Exercise Notice Warrant Shares are
freely tradeable upon issuance to the Holder notwithstanding the unavailability of a registration statement and such shares do
not bear any restrictive legend) and together with the event described in clause (I) above, an “Exercise Failure”),
then, in addition to all other remedies available to the Holder, if on or prior to the applicable Warrant Share Delivery Date
either (I) (x) if the Company’s transfer agent is not participating in FAST and the Company shall have failed to issue and
deliver a certificate to the Holder and register such shares of Common Stock on the Company’s share register or, (y) if
the Company’s transfer agent is participating in FAST and the Company shall have failed to credit the Holder’s balance
account with DTC the number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise hereunder
or pursuant to the Company’s obligation pursuant to clause (ii) below, or (II) if a Notice Failure occurs, and if after
such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s
brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares
issuable hereunder pursuant to such exercise and which the Holder anticipated receiving upon such exercise (a “Buy-In”),
then the Company shall, within five (5) Trading Days after the Holder’s request, (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common
Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required
to deliver to the Holder in connection with the exercise at issue multiplied by (2) the price at which the sell order giving rise
to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and
equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with
its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price
of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in
respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit the Holder’s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon
exercise of this Warrant as required pursuant to the terms hereof. In addition to the foregoing rights, (i) if the Company fails
to deliver the applicable number of Warrant Shares upon an exercise pursuant to Section 2(d)(i) by the applicable Warrant Share
Delivery Date, then the Holder shall have the right to rescind such exercise in whole or in part and

 

    7

     

    

retain and/or have the
Company return, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Notice of
Exercise; provided that the rescission of an exercise shall not affect the Company’s obligation to make any
payments that have accrued prior to the date of such notice pursuant to this Section 2(d)(iii) or otherwise, and (ii) if a
registration statement covering the issuance or resale of the Warrant Shares that are subject to a Notice of Exercise is not
available for the issuance or resale, as applicable, of such Exercise Notice Warrant Shares and the Holder has submitted a
Notice of Exercise prior to receiving notice of the non-availability of such registration statement and the Company has not
already delivered the Warrant Shares underlying such Notice of Exercise electronically without any restrictive legend by
crediting such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the
Holder’s or its designee’s balance account with DTC through its Deposit / Withdrawal At Custodian system, the
Holder shall have the option, by delivery of notice to the Company, to (x) rescind such Notice of Exercise in whole or in
part and retain or have returned, as the case may be, any portion of this Warrant that has not been exercised pursuant to
such Notice of Exercise; provided that the rescission of a Notice of Exercise shall not affect the Company’s obligation
to make any payments that have accrued prior to the date of such notice pursuant to this Section 2(d)(iii) or otherwise,
and/or (y) to the extent permitted hereunder, switch some or all of such Notice of Exercise from a cash exercise to a
“cashless exercise” pursuant to Section 2(c). In addition to the foregoing, if the Company fails for any reason
to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the third Trading Day following the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the Weighted Average Price of the Common Stock on the date of the
applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such
liquidated damages begin to accrue) for each Trading Day after the Share Delivery Date until such Warrant Shares are
delivered or Holder rescinds such exercise; provided, however, that, notwithstanding the foregoing, (i) with
respect to any particular Notice of Exercise, the Holder shall not be entitled to recover any liquidated damages from the
Company pursuant to this sentence above in connection with any failure to deliver any Exercise Notice Warrant Shares to the
Holder subject to such Notice of Exercise until the aggregate liquidated damages for which the Company would otherwise be
liable in respect of all failures to deliver Exercise Notice Warrant Shares hereunder (in the absence of this limitation)
exceeds $25,000 (the “LD Threshold”), after which the Holder shall be paid the aggregate amount of all
such liquidated damages in respect of all such failures to deliver Exercise Notice Warrant Shares hereunder from the first
dollar thereof (including the amount of the LD Threshold), and (ii) the maximum aggregate liquidated damages (cumulatively,
inclusive of any and all liquidated damages under this sentence) for which the Company will be liable will in no event exceed
an amount equal to (A) $1,000,000, multiplied by (B) a fraction (1) the numerator of which is the initial total
number of Warrant Shares in respect of which this Warrant may be exercised as of the Issuance Date, and (2) the denominator
of which is 9,000,000, in each case, as proportionately adjusted in accordance with the provisions of Section 3 hereof.

 

    8

     

    

 

iv.                 
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such
exercise, the Company shall, at its election, either (x) pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction, multiplied by the Exercise Price or (y) round up to the next whole share.

 

v.                 
Taxes. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax in respect
of the issuance of such Warrant Shares, all of which taxes shall be paid by the Company, and such Warrant Shares shall be issued
in the name of the Holder or in such name or names as may be directed by the Holder to the extent permitted under this Warrant;
provided, however, that in the event that Warrant Shares are to be so issued in a name other than the name of the
Holder, this Warrant when surrendered for exercise shall be accompanied by the assignment form attached hereto duly executed by
the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. For income tax purposes, the Holder agrees that the Company may withhold from any amounts payable to the
Holder or its permitted assignee or permitted transferee any taxes to be withheld from such amounts; provided that the Company
shall use reasonable efforts to notify the Holder of the Company’s intention to withhold such taxes and the reason therefor
prior to such withholding and the Company shall reasonably cooperate with the Holder to reduce or eliminate the amounts required
to be withheld.

 

vi.                 
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely
exercise of this Warrant, pursuant to the terms hereof.

 

    9

     

    

 

Section 3.                     Certain
Adjustments.

 

a)                  Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) subdivides outstanding shares of
Common Stock into a larger number of shares, (ii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares or (iii) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant (and the limitations set forth in Sections 2(a)(i)-(v)) shall be
proportionately adjusted such that the Aggregate Exercise Price in respect of the Warrant Shares that remain subject to this
Warrant at such time shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a subdivision, combination or
re-classification.

 

    10

     

    

 

 

b)                  Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer,
tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or
property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50%
of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons
making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase
agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction (as if the exercise of this Warrant
occurred immediately prior to the occurrence of such Fundamental Transaction), the number of shares of common stock of the
successor or acquiring corporation (if such successor or acquiring corporation assumed the obligations under this Warrant by
operation of law, provided that, in the absence of such assumption, immediately prior to the Fundamental Transaction, this
Warrant shall be automatically exercised via cashless exercise without any action on the part of the Holder) or shares of
Common Stock of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate
Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of
Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes of any
such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such
Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction.

 

    11

     

    

 

c)                 
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a
share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
Notwithstanding anything to the contrary in this Section 3, if at any time the Exercise Price upon any adjustment thereto would
be less than par value per share of Common Stock, then the Exercise Price shall equal such par value.

 

d)                 
Notice to Holder of Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall within five (5) Trading Days deliver to the Holder by facsimile or email a notice setting
forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a
brief statement of the facts requiring such adjustment.

 

e)                  Rights
Upon Distribution of Assets. In addition to any adjustments pursuant to this Section 3 above, if, on or after the Issue
Date and on or prior to the Expiration Date, the Company shall declare or make any dividend or other distribution of its
assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property, options, evidence of
indebtedness or any other assets by way of a dividend, spin-off, reclassification, corporate rearrangement, scheme of
arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this
Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that
the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon
complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including
without limitation, the Maximum Percentage) immediately before the date on which a record is taken for such Distribution, or,
if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
participation in such Distribution (provided, however, that to the extent that the Holder's right to
participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (and shall not be
entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership)
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time
or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on
such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had
been no such limitation).

 

    12

     

    

 

Section
4.                     Transfer of Warrant.

 

a)                 
Transferability. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder
(including, without limitation, any registration rights) are transferable to any Person, in whole or in part (but if in part, then
only in increments representing 25,000 Warrant Shares issuance pursuant hereto), upon surrender of this Warrant at the principal
office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the Permitted Fund Transferee or Permitted Fund Transferees, as applicable, and in the denomination or denominations
specified in such instrument of assignment (provided that no new Warrant shall be exercisable for less than 25,000 Warrant Shares),
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.

 

b)                 
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid
office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney; provided that no new Warrant shall be exercisable for less than 25,000 Warrant Shares.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for this Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the original issue date and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)                 
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that
purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may
deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any
distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

d)                 
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that:

 

i.           
it is an “accredited investor” as defined in Regulation D of the Securities
Act; 

 

    13

     

    

 

ii.           
it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise,
for investment for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof
in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under
the Securities Act.

 

iii.           
it understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted
securities” under the federal securities laws and may not be offered, sold, pledged or otherwise transferred expect (A) pursuant
to an exemption from registration under the Securities Act and, if the Company requests, upon delivery of an opinion of counsel
to such effect, in form and substance reasonably satisfactory to the Company or (B) pursuant to an effective registration statement
under the Securities Act, in each case in accordance with all applicable state securities laws and the securities laws of other
jurisdictions; and

 

iv.           
it can bear the economic and financial risk of its investment for an indefinite period and has such knowledge and experience
in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant and the
Warrant Shares.

 

e)                 
Removal of Legends.

 

i.        
Until such time as the Warrant Shares have been sold pursuant to an effective registration statement under the Securities
Act, or the Warrant Shares are eligible for resale pursuant to Rule 144 promulgated under the Securities Act without any restriction
as to the number of securities as of a particular date that can then be immediately sold, any certificate(s) representing the Warrant
Shares sold pursuant to this Agreement will be imprinted (and any Warrant Shares issued in book entry form will have a notation
in the Company’s stock transfer records) with a legend in substantially the following form:

 

THE SECURITIES
EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES EVIDENCED BY THIS CERTIFICATE MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT and,
if the Company requests, upon delivery of an opinion of counsel to such effect, in form and substance reasonably satisfactory
to the Company OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE
WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE SECURITIES LAWS OF OTHER JURISDICTIONS.

 

    14

     

    

 

ii.        
Certificates evidencing the Warrant Shares shall not contain any legend (including the legend set forth in Section 4(e)(i)
hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, (ii) if
such Warrant Shares are eligible for sale under Rule 144, or (iii) if such legend is not required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). If all or
any portion of this Warrant is exercised at a time when there is an effective registration statement to cover the resale of the
Warrant Shares, or if such Warrant Shares may be sold under Rule 144 or if such legend is not otherwise required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission)
then such Warrant Shares shall be issued free of all legends. The Company agrees that following such time as such legend is no
longer required under this Section 4(e)(iii) and upon the request of the Holder, the Company will, no later than five (5) Trading
Days following the delivery by a Holder to the Company of a certificate representing Warrant Shares, as applicable, issued with
a restrictive legend (such third Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to
such Holder a certificate representing such shares that is free from all restrictive and other legends.

 

f)                  
Registration Rights. If at any time the Company shall determine to (x) prepare and file with the SEC a registration
statement for the sale of Common Stock or other equity securities of the Company, or (y) sell shares of Common Stock or other equity
securities of the Company in an underwritten offering pursuant to a registration statement filed with the SEC on Form S-3 (or any
successor form or other appropriate form promulgated under the Securities Act) for an offering to be made on a continuous or delayed
basis pursuant to Rule 415 promulgated under the Securities Act, in each case, either for its own account or for the account of
other holders of equity securities in the Company, the Company shall (i) promptly, but no less than ten (10) Business Days prior
to the anticipated filing date of the registration statement (in the case of clause (x) above) or such sale (in the case of clause
(y) above), give to each holder of Warrant Shares written notice thereof and (ii) subject to customary limitations (including,
without limitation, underwriter cutbacks) and receipt of customary information, representations and undertakings from the Holder,
include in such registration statement or sale, as applicable, all Warrant Shares specified in a written request or requests, made
by the holders of the Warrant Shares within five (5) Business Days after receipt of the notice from the Company described in clause
(i) above. For the avoidance of doubt, this Section 4(f) shall survive the exercise in full of this Warrant or, if this
exercise shall have been exercised in part or in full prior to such termination, the termination of this Warrant.

 

    15

     

    

 

Section 5.                     Miscellaneous.

 

a)                 
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).

 

b)                 
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to
the Warrant Shares, and in case of loss, theft or destruction, of an affidavit of loss and indemnity or security reasonably satisfactory
to it (which, in the case of this Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such
Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor
and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c)                 
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of
any right required or granted in this Warrant is not a Business Day, then, such action may be taken or such right may be exercised
on the next succeeding Business Day.

 

d)                 
Authorized Shares.

 

i.        
During the period this Warrant is outstanding from and after the Issue Date, the Company covenants that it will reserve
from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon
the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute
full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided in this Warrant without violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this
Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect
of any transfer occurring contemporaneously with such issue or the Holder’s income taxes).

 

ii.         Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such
terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth
in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the
par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in
par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally
issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction
thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

    16

     

    

 

iii.        
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable
or in the Exercise Price, the Company shall use commercially reasonable efforts to obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

iv.         In
addition to the foregoing, in the event of any failure by the Company to reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant that results in the failure of the Company to deliver any shares of Common Stock that would have
otherwise been deliverable pursuant to a Notice of Exercise (such shares the “Authorized Shares Failure
Shares”), (1) the Company will promptly pay to the Holder, as liquidated damages and not as a penalty, cash in an
amount equal (i) to the product of (x) the number of such Authorized Shares Failure Shares; and (y) the Daily VWAP per share
of Common Stock on the date the Holder delivered the applicable Notice of Exercise hereunder (or, if such date is not a VWAP
Trading Day, the immediately preceding VWAP Trading Day), minus (ii) if such exercise is not a cashless exercise the
Aggregate Exercise Price applicable to such Authorized Shares Failure Shares, to the extent not previously paid; and (2) to
the extent the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in settlement
of a sale by the Holder of such Authorized Shares Failure Shares, the Company will reimburse the Holder for (x) any brokerage
commissions and other out-of-pocket expenses, if any, of the Holder incurred in connection with such purchases and (y) the
excess, if any, of (A) the aggregate purchase price of such purchases over (B) an amount equal to (i) the product of (I) the
number of such Authorized Shares Failure Shares purchased by the Holder; and (II) the Daily VWAP per share of Common Stock on
the date the Holder delivered the applicable Notice of Exercise hereunder (or, if such date is not a VWAP Trading Day, the
immediately preceding VWAP Trading Day), minus (ii) if such exercise is not a cashless exercise, the Aggregate
Exercise Price applicable to such Authorized Shares Failure Shares, to the extent not previously paid.

 

    17

     

    

 

e)                 
Jurisdiction. This Warrant shall be interpreted and enforced in accordance with and governed by the laws of the State
of Delaware applicable to agreements made and to be performed wholly within that jurisdiction without regard to conflicts of laws
principles thereof that would result in the application of the law of any other jurisdiction.

 

f)                  
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not
registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities
laws.

 

g)                 
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part
of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding
the fact that all rights hereunder (other than the Holder’s rights set forth in Section 4(f)) terminate on the Termination
Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any out-of-pocket costs
and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h)                 
Notices. All notices and other communications provided for hereunder shall be (i) in writing (including facsimile
and email) and (ii) sent by facsimile, email or overnight courier (if for inland delivery) or international courier (if for overseas
delivery) to a party hereto at its address and contact number specified below, or at such other address and contact number as is
designated by such party in a written notice to the other parties hereto:

 

 i.        The Company:

 

	 	 	
        Tellurian Inc.

        1201 Louisiana St

        Suite 3100

        Houston, TX 77002

        Attention: Legal

        Email: legal.notices@tellurianinc.com

 

    18

     

    

 

ii.        The Holder:

 

	 	 	
        Nineteen77 Capital Solutions A LP

        c/o UBS O’Connor LLC

        787 7th Avenue, 13th Floor

        New York, NY 10019

        Attention: Rodrigo Trelles

        Email: OL-OCS@ubs.com

         

	with copies (which shall not constitute notice) to:	 	
        Nineteen77 Capital Solutions A LP

        c/o UBS O’Connor LLC

        UBS Tower

        1 N. Wacker Drive

        Chicago, IL 60606

        Attention: Andrew Hollenbeck

        Email: andrew.hollenbeck@ubs.com

         

	with copies (which shall not constitute notice) to:	 	
        Latham & Watkins LLP

        885 Third Avenue

        New York, NY 10022

        Attention: Matthew Henegar

        Telephone No.: 212-906-1814

        Email: matthew.henegar@lw.com

         

        Latham & Watkins LLP

        885 Third Avenue

        New York, NY 10022

        Attention: David E. Owen

        Telephone No.: 212-906-4503

        Email: david.owen@lw.com

 

All notices and communications
shall be effective when received by the addressee thereof during business hours on a Business Day in such Person’s location
as indicated by such Person’s address above, or at such other address as is designated by such Person in a written notice
to the other parties hereto.

 

i)                  
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise
this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to
any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.

 

    19

     

    

 

j)                  
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of
damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)                 
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced
hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors
and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time
of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)                  
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the
Company and the Holder.

 

m)              
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

n)                 
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant.

 

o)                 
Tax Treatment. This Warrant has been issued as part of an “investment unit” (within the meaning of Treasury
Regulations Section 1.1273-2(h)), consisting of this Warrant and loans advanced by the Holder pursuant to the Credit and Guaranty
Agreement. The Company and the Holder agree that solely for purposes of Treasury Regulations Section 1.1273-2(h), the initial issue
price of such loans and the fair market value and purchase price of this Warrant shall be amounts reasonably agreed by the Holder
and the Company within thirty (30) days after the Issue Date. The Company and the Holder shall file all income tax returns consistent
with the foregoing tax treatment, including the issue price and purchase price specified in the preceding sentence.

 

    20

     

    

 

p)                  Limitation
on Exercise. Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any
portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the
terms and conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the extent
that after giving effect to such exercise, the Holder together with the other Attribution Parties collectively would
beneficially own in the aggregate in excess of 9.99% (the “Maximum Percentage”) of the number of shares of
Common Stock outstanding immediately after giving effect to such exercise. For purposes of this Section 5(p), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the
“1934 Act”). For purposes of this Warrant, in determining the number of outstanding shares of Common Stock
the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the
number of outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K,
Quarterly Report on Form 10-Q and Current Reports on Form 8-K or other public filing with the Securities and Exchange
Commission (the “SEC”), as the case may be, (y) a more recent public announcement by the Company or (z)
any other written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding
(the “Reported Outstanding Share Number”). If the Company receives an Exercise Notice from the Holder at a
time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the
Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent
that such Exercise Notice would otherwise cause the Holder’s beneficial ownership, as determined pursuant to this
Section 5(p), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to
be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the
“Reduction Shares”) and (ii) as soon as reasonably practicable, the Company shall return to the Holder the
Aggregate Exercise Price (or applicable portion thereof) paid by the Holder for the Reduction Shares. For any reason at any
time, upon the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in
writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported
Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this
Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than
the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934
Act), the number of shares so issued by which the Holder’s and the other Attribution Parties’ aggregate
beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void
and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As soon
as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to
the Holder the Aggregate Exercise Price (or applicable portion thereof) paid by the Holder for the Excess Shares. Upon
delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to
any other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum
Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company
and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other
holder of Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock
issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially
owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior
inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of
this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 5(p) to the extent
necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended
beneficial ownership limitation contained in this Section 5(p) or to make changes or supplements necessary or desirable to
properly give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a
successor holder of this Warrant. The Holder hereby acknowledges and agrees that the Company shall be entitled to rely on the
representations and other information set forth in any Exercise Notice and shall not be required to independently verify
whether any exercise of this Warrant would cause the Holder (together with the other Attribution Parties) to collectively
beneficially own in excess of the Maximum Percentage of the number of shares of Common Stock outstanding after giving effect
to such exercise or otherwise trigger the provisions of this Section 5(p).

 

********************

 

(Signature Page Follows)

 

    21

     

    

 

 

 

IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	 	TELLURIAN INC.
	 	 
	 	By:	 /s/ Kian Granmayeh
	 	 	Name: Kian Granmayeh
	 	 	Title:   Chief Financial Officer

 

[Signature
page to Amended Warrant]

 

     

     

    

 

NOTICE OF EXERCISE

 

To:TELLURIAN
INC.

 

(1)  
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full.

 

(2)  
Exercise Price: $

 

(3)  
Payment shall take the form of (check applicable box):

 

[ ] in lawful
money of the United States; or

 

[ ] the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this
Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth
in subsection 2(c).

 

(4)  
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

(5)  
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated
under the Securities Act of 1933, as amended, and reaffirms as of the date hereof, the representations and warranties set forth
in Section 4(d) of the Warrant.

 

(6)  
Maximum Percentage Representation. Notwithstanding anything to the contrary contained herein, this Notice of Exercise
shall constitute a representation by the Holder that, after giving effect to the exercise provided for in this Notice of Exercise,
the Holder (together with the other Attribution Parties) will not have beneficial ownership of a number of shares of Common Stock
in excess of the Maximum Percentage of the total outstanding shares of Common Stock of the Company as determined pursuant to the
provisions of Section 5(p) of the Warrant and utilizing a Reported Outstanding Share Number (as provided or reported by the Company,
as applicable) equal to ______________.

 

[SIGNATURE
OF HOLDER]

 

	Name of Investing Entity:	  
	Signature of Authorized Signatory of Investing Entity:	  
	Name of Authorized Signatory:	  
	Title of Authorized Signatory:	  
	Date:	  
	Address:	  

 

     

     

    

 

ASSIGNMENT
FORM

 

(To assign the foregoing Warrant, execute
this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to

 

	Name:	 	 
	 	(Please Print)	 
	 	 	 
	Address:	 	 
	 

         

        Phone
        Number:

         

        Email
        Address: 

         
	(Please Print)

         

        ________________________________________________

         

        ________________________________________________
	

         

	Dated: _______________
    __, ______	 	 
	 	 	 
	Holder’s
    Signature:                                      	 	 
	 	 	 
	Holder’s
    Address:Exhibit 10.1

 

VOTING AGREEMENT

 

This VOTING AGREEMENT
(this “Agreement”), dated as of April 29, 2020, is entered into by and between the undersigned stockholder (the
“Stockholder”) of Tellurian Inc., a Delaware corporation (the “Company”), and the Company.
The Company and the Stockholder are each sometimes referred to herein individually as a “Party” and collectively
as the “Parties.” Capitalized terms that are used but not defined herein shall have the meaning ascribed to
them in the Purchase Agreement (as defined below).

 

RECITALS

 

A.                
Concurrently with or following the execution of this Agreement, the Company has entered, or will enter, into a Securities
Purchase Agreement (as the same may be amended from time to time, the “Purchase Agreement”), providing for,
among other things, the sale to the Buyers of the Purchased Securities pursuant to the terms and conditions of the Purchase Agreement
and the Transaction Documents.

 

B.                 
In order to induce the Buyers to enter into the Purchase Agreement and the Transaction Documents, and for good and valuable
consideration, the sufficiency of which is hereby acknowledged, the Stockholder hereby makes certain representations, warranties,
covenants, and agreements as set forth in this Agreement with respect to the shares of Common Stock Beneficially Owned by the
Stockholder and set forth below the Stockholder’s signature on the signature page hereto (the “Original Shares”
and, together with any additional shares of Common Stock pursuant to Section 6 hereof, the “Shares”).
[Notwithstanding the foregoing, the Common Stock Beneficially Owned by the Stockholder shall not include the 1,300,000 shares
of Common Stock owned by the Stockholder’s wife as set forth on Exhibit A, and such shares of Common Stock shall
not be included in “Original Shares” or “Shares”.]1

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

 

1.            Definitions. For purposes of this Agreement, capitalized terms used and not otherwise defined herein
shall have the respective meanings ascribed to such terms in the Purchase Agreement. When used in this Agreement, the following
terms in all of their tenses, cases, and correlative forms shall have the meanings assigned to them in this Section 1.

 

(a)               
“Beneficially Own” or “Beneficial Ownership” has the meaning assigned to such
term in Rule 13d-3 under the 1934 Act, and a Person’s beneficial ownership of securities shall be calculated in accordance
with the provisions of such rule (in each case, irrespective of whether or not such rule is actually applicable in such circumstance).
For the avoidance of doubt, “Beneficially Own” and “Beneficial Ownership” shall also include record ownership
of securities.

 

(b)               
“Beneficial Owner” shall mean the Person who Beneficially Owns the referenced securities.

 

2.          
 Representations of Stockholder. The Stockholder represents and warrants to the Company
that:

 

(a)                Ownership
of Shares. The Stockholder: (i) is the Beneficial Owner of all of the Original Shares set forth below the
Stockholder’s signature on the signature pages hereto free and clear of any proxy, voting restriction, adverse claim,
or other Liens, other than those created by this Agreement or under applicable federal or state securities laws, except as
set forth on Exhibit A hereto and (ii) has the sole voting power over all such Original Shares, except as set
forth on Exhibit A. Except pursuant to this Agreement or as set forth on Exhibit A hereto, there are
no options, warrants, or other rights, agreements, arrangements, or commitments of any character to which the Stockholder is
a party relating to the pledge, disposition, or voting of any such Original Shares and there are no voting trusts or voting
agreements with respect to such Original Shares.

 

 

1
The bracketed language in Recital B is included in the Voting Agreement with Martin Houston and is excluded from
the Voting Agreements with each of Charif Souki, Meg Gentle and R. Keith Teague.

 

    

     

    

 

(b)               
Disclosure of All Shares Owned. The Stockholder does not Beneficially Own any shares of Company Common Stock
other than: (i) the Original Shares set forth below the Stockholder’s signature on the signature pages hereto; and (ii) any
options, warrants, or other rights to acquire any additional shares of Company Common Stock or any security exercisable for or
convertible into shares of Company Common Stock, set forth below the Stockholder’s signature on the signature pages hereto
(collectively, “Options”).

 

(c)               
Power and Authority; Binding Agreement. If the Stockholder is an individual, the Stockholder has full power
and authority and legal capacity to enter into, execute, and deliver this Agreement and to perform fully the Stockholder’s
obligations hereunder (including the proxy described in Section 3(b) below). If the Stockholder is not an individual,
the Stockholder has the organizational power and authority to enter into, execute, and deliver this Agreement and to perform fully
the Stockholder’s obligations hereunder (including the proxy described in Section 3(b) below). This Agreement
has been duly and validly executed and delivered by the Stockholder and constitutes the legal, valid, and binding obligation of
the Stockholder, enforceable against the Stockholder in accordance with its terms.

 

(d)               
No Conflict. The execution and delivery of this Agreement by the Stockholder does not, and the consummation
of the transactions contemplated hereby and the compliance with the provisions hereof will not, conflict with or violate any law
applicable to the Stockholder or result in any breach of or violation of, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration, or
cancellation of, or result in the creation of any Lien on any of the Shares attributable to the Stockholder pursuant to, any agreement
or other instrument or obligation binding upon the Stockholder or any of the Shares attributable to the Stockholder.

 

(e)               
No Consents. No consent, approval, order, or authorization of, or registration, declaration, or filing with,
any Governmental Entity or any other Person on the part of the Stockholder is required in connection with the valid execution and
delivery of this Agreement. If the Stockholder is an individual, no consent of the Stockholder’s spouse is necessary under
any “community property” or other laws in order for the Stockholder to enter into and perform its obligations under
this Agreement.

 

(f)                
No Litigation. There is no action, suit, investigation, or proceeding (whether judicial, arbitral, administrative,
or other) pending against, or, to the knowledge of the Stockholder, threatened against or affecting, the Stockholder that could
reasonably be expected to materially impair or materially adversely affect the ability of the Stockholder to perform the Stockholder’s
obligations hereunder or to consummate the transactions contemplated by this Agreement on a timely basis.

 

3.           
Agreement to Vote Shares; Irrevocable Proxy.

 

(a)                Agreement
to Vote and Approve. The Stockholder irrevocably and unconditionally agrees during the term of this Agreement, at any
annual or special meeting of the Company called with respect to (i) the approval contemplated by Nasdaq Listing Standard Rule
5635(d) with respect to the issuance of shares of Common Stock upon conversion of, or in exchange for, the Convertible Notes
(as defined below) in excess of the limitations imposed by such rule and/or (ii) approving an increase in the Company’s
authorized but unissued shares to allow it to comply both with the first sentence of Section 10(D)(v) of the Convertible
Notes and its obligation to issue up to twenty million (20,000,000) shares of its Common Stock pursuant to the Warrants (as
defined below), and at every adjournment or postponement thereof, and on every action or approval by written consent or
consents of the Company stockholders with respect to such matter, to vote or cause the holder of record to vote the Shares
(except for Shares Transferred in accordance with Section 5) in favor of providing the Requisite Stockholder
Approval (as defined in the Convertible Notes) and the Share Authorization Increase (as defined in the Purchase Agreement).
“Convertible Notes” and “Warrants” mean the Senior Unsecured Notes and Warrants to
purchase Common Stock issued pursuant to the Purchase Agreement, as amended from time to time.

 

    2

     

    

 

(b)               
Irrevocable Proxy. The Stockholder hereby appoints the Company and any designee of the Company, and each of
them individually, until the Expiration Time (at which time this proxy shall automatically be revoked), its proxies and attorneys-in-fact,
with full power of substitution and resubstitution, to vote or act by written consent during the term of this Agreement with respect
to the Shares (except for Shares Transferred in accordance with Section 5) in accordance with Section 3(a).
This proxy and power of attorney is given to secure the performance of the duties of the Stockholder under this Agreement. The
Stockholder shall take such further action or execute such other instruments as may be necessary to effectuate the intent of this
proxy. This proxy and power of attorney granted by the Stockholder shall be irrevocable during the term of this Agreement, shall
be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy, and shall revoke any and all prior
proxies granted by the Stockholder with respect to the Shares. The power of attorney granted by the Stockholder herein is a durable
power of attorney and shall survive the bankruptcy, death, or incapacity of the Stockholder. The proxy and power of attorney granted
hereunder shall terminate upon the termination of this Agreement.

 

4.             No
Voting Trusts or Other Arrangement. Except for Shares Transferred in accordance with Section 5, The Stockholder
agrees that during the term of this Agreement the Stockholder will not, and will not permit any entity under the Stockholder’s
control to, deposit any of the Shares in a voting trust, grant any proxies with respect to the Shares, or subject any of the Shares
to any arrangement with respect to the voting of the Shares, in each case other than agreements entered into with the Company.

 

5.             Transfer
and Encumbrance. Except for any pledges of Original Shares in effect as of the date hereof and set forth on Exhibit A
hereto, the Stockholder agrees that until the earlier of (a) the termination of this Agreement and (b) June 30, 2020 (unless
with respect to this clause (b), the Requisite Stockholder Approval and the Share Authorization Increase have not been obtained
on or prior to such date, in which case such date shall be extended to August 31, 2020), the Stockholder will not, directly
or indirectly, transfer, sell, offer, exchange, assign, pledge, convey any legal or Beneficial Ownership interest in or otherwise
dispose of (by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange
offer, by testamentary disposition, by operation of law, or otherwise), or encumber (“Transfer”) any of the
Shares or enter into any contract, option, or other agreement with respect to, or consent to, a Transfer of, any of the Shares
or the Stockholder’s voting or economic interest therein[; provided that the Stockholder shall be permitted to Transfer
up to 10,000,000 Shares during the term of this Agreement].2 Any attempted Transfer of Shares or any interest therein
in violation of this Section 5 shall be null and void. This Section 5 shall not prohibit a Transfer of
the Shares by the Stockholder to any member of the Stockholder’s immediate family, to a trust for the benefit of the Stockholder
or any member of the Stockholder’s immediate family, upon the death of the Stockholder or to an “affiliate”
(as defined in Rule 144) of the Stockholder; provided, that a Transfer referred to in this sentence shall be permitted only if,
as a precondition to such Transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to the Company
and the Buyers, to be bound by all of the terms of this Agreement.

 

6.             Additional
Shares. The Stockholder agrees that all shares of Common Stock that the Stockholder purchases, acquires the right to
vote, or otherwise acquires Beneficial Ownership of, after the execution of this Agreement and prior to the Expiration Time
shall be subject to the terms and conditions of this Agreement and shall constitute Shares for all purposes of this
Agreement. In the event of any stock split, stock dividend, merger, reorganization, recapitalization, reclassification,
combination, exchange of shares, or the like of the capital stock of the Company affecting the Shares, the terms of this
Agreement shall apply to the resulting securities and such resulting securities shall be deemed to be “Shares”
for all purposes of this Agreement.

 

 

2 The
bracketed language in Section 5 is included in the Voting Agreement with Martin Houston and is excluded from the Voting
Agreements with each of Charif Souki, Meg Gentle and R. Keith Teague.

 

    3

     

    

 

7.                  Termination.
This Agreement shall terminate upon the earliest to occur of (the “Expiration Time”): (a) the date on which
the Purchase Agreement is terminated in accordance with its terms; (b) the termination of this Agreement by mutual written consent
of the Parties; and (c) the date on which the Requisite Stockholder Approval and the Share Authorization Increase are obtained.
Nothing in this Section 7 shall relieve or otherwise limit the liability of any Party for any intentional breach of
this Agreement prior to such termination.

 

8.                 
No Agreement as Director or Officer. The Stockholder makes no agreement or understanding in this
Agreement in its capacity as a director or officer of the Company or any of its subsidiaries (if the Stockholder holds such office),
and nothing in this Agreement: (a) will limit or affect any actions or omissions taken by the Stockholder in its capacity as such
a director or officer, and no such actions or omissions shall be deemed a breach of this Agreement; or (b) will be construed to
prohibit, limit, or restrict the Stockholder from exercising its fiduciary duties as an officer or director to the Company or its
stockholders.

 

9.                 
Further Assurances. The Stockholder agrees, from time to time, and without additional consideration,
to execute and deliver such additional proxies, documents, and other instruments and to take all such further action as the Company
may reasonably request to consummate and make effective the transactions contemplated by this Agreement.

 

10.               
Stop Transfer Instructions. At all times commencing with the execution and delivery of this Agreement
and continuing until the Expiration Time, in furtherance of this Agreement, the Stockholder hereby authorizes the Company or its
counsel to notify the Company’s transfer agent that there is a stop transfer order with respect to all of the Shares (and
that this Agreement places limits on the voting and transfer of the Shares), subject to the provisions hereof and provided that
any such stop transfer order and notice will immediately be withdrawn and terminated by the Company following the Expiration Time.

 

11.              
Specific Performance. Each Party hereto acknowledges that it will be impossible to measure in money
the damage to the other Party if a Party hereto fails to comply with any of the obligations imposed by this Agreement, that every
such obligation is material and that, in the event of any such failure, the other Party will not have an adequate remedy at law
or damages. Accordingly, each Party hereto agrees that injunctive relief or other equitable remedy, in addition to remedies at
law or damages, is the appropriate remedy for any such failure and will not oppose the seeking of such relief on the basis that
the other Party has an adequate remedy at law. Each Party hereto agrees that it will not seek, and agrees to waive any requirement
for, the securing or posting of a bond in connection with the other Party’s seeking or obtaining such equitable relief.

 

12.               Assignment.
No Party to this Agreement may assign any of its rights or obligations under this Agreement without the prior written consent
of the other Party hereto, except that the Company may assign, in its sole discretion, all or any of its rights, interests
and obligations hereunder to any of its “affiliates” (as defined in Rule 144 under the 1933 Act) or to any party
that acquires all of substantially all of the assets of the Company (whether by merger, sale of stock, sale of assets or
otherwise). Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be
enforceable by the Parties and their respective permitted successors and assigns. Any assignment contrary to the provisions
of this Section 12 shall be null and void.

 

    4

     

    

 

13.              
Notices. Any notices, consents, waivers or other communications required or permitted to be given
under the terms of this Agreement must be in writing and will be deemed to have been delivered:  (i) upon receipt, when
delivered personally; (ii) upon receipt, when sent by electronic mail (provided that such sent email is kept on file (whether
electronically or otherwise) by the sending party and the sending party does not receive an automatically generated message from
the recipient’s email server that such e-mail could not be delivered to such recipient); or (iii) one (1) Business
Day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the party
to receive the same.  The addresses, facsimile numbers and e-mail addresses for such communications shall be:

 

     If to the Company:

 

Tellurian Inc.

1201 Louisiana Street, Suite 3100

Houston, TX 77002

Attention: Daniel Belhumeur, General
Counsel

E-mail: Daniel.Belhumeur@tellurianinc.com

 

     With a copy (for informational
purposes only) to:

 

Davis Graham & Stubbs LLP

1550 17th St., Suite 500

Denver, CO 80202

Attention: John Elofson

E-mail: john.elofson@dgslaw.com

 

     If to the Stockholder, to the
address, email address, or facsimile number set forth for the Stockholder on the signature pages hereof.

 

14.              
Miscellaneous. The provisions of Sections 9(a), (b), (c), (d), (e), (g), (h), and (l) of the
Purchase Agreement shall apply to this Agreement, mutatis mutandis.

 

[Remainder
of Page Intentionally Left Blank]

 

    5

     

    

 

IN WITNESS WHEREOF,
the Parties hereto have executed and delivered this Agreement as of the date first written above.

 

	 	TELLURIAN INC.
	 	 	 
	 	By:	              
	 	Name:	 
	 	Title:	 
	 	 	 
	 	[STOCKHOLDER]
	 	 	 
	 	By:	 
	 	Name:	 
	 	 	 
	 	
        Number of Shares of Company Common Stock
        Beneficially Owned as of the date of this Agreement:

         

	 	
        Number of Options Beneficially Owned as
        of the date of this Agreement:

         

	 	
        Street Address:

        City/State/Zip Code:

        Email:

 

    

     

    

 

Exhibit A

 

[Signature Page to Voting Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]